New treatment regimen may decrease mortality in patients with cardiotoxicity from immune checkpoint inhibitors
Among cancer patients who developed cardiotoxicity after treatment with immune checkpoint inhibitor (ICI) therapy, those treated with abatacept (Orencia), ruxolitinib, and/or mechanical ventilation as needed had a significantly ...
Feb 23, 2023
0
43
